Jing Hao
感谢各位参加本次电话会议。接下来,我代表管理层总结2020年第四季度的一些关键财务业绩。同时,我会不时提及与各类产品相关的特定生产线。我会明确说明我所指的产品。作为参考,我们的生产线编号系统请见幻灯片第18页。现在让我们来看2020年第四季度的财务表现。请翻到幻灯片第7页。2020年第四季度,由于CMP和胶版印刷纸销量下降,总收入下降3.4%至3250万美元。翻到幻灯片第8页。2020年第四季度,CMP业务板块(包括常规CMP和轻量CMP)实现收入2490万美元,占总收入的76.7%。其中1970万美元收入来自常规CMP产品,520万美元来自轻量CMP。CMP板块销量小幅下降3.4%至57,627吨,其中45,210吨为常规CMP,12,417吨为轻量CMP。常规CMP的平均售价(ASP)上涨4.3%至每吨435美元,轻量CMP的ASP为每吨422美元。翻到幻灯片第9页。2020年第四季度,胶版印刷纸实现收入490万美元,较去年同期下降230万美元或31.9%。胶版印刷纸销量下降24.4%至7,895吨。胶版优质纸的ASP下降9.8%至每吨618美元。翻到幻灯片第10页。生活用纸产品实现收入260万美元,增加90万美元或51.3%。这源于生活用纸产品销售3,165吨,增长51.3%。ASP为每吨837美元,增长22.4%。翻到幻灯片第11页。2020年第四季度,我们售出445,000片口罩,通过销售口罩产生收入114万美元[ph]。幻灯片第12页总结了我们的收入结构变化。2020年第四季度,总销售成本增加370万美元至3170万美元,导致总毛利润为70万美元,而去年同期毛利润为560万美元,2020年第四季度整体毛利率为2.3%。2020年第四季度,销售、一般及行政费用增长14.6%至270万美元,运营亏损为200万美元,而去年同期运营收入为320万美元。运营利润率为负6.1%,而去年同期运营利润率为9.5%。2020年第四季度,净亏损为270万美元,导致基本和稀释每股净亏损0.06美元。相比之下,去年同期净利润为220万美元,基本和稀释每股净利润为0.10美元。2020年第四季度,息税折旧摊销前利润下降540万美元至160万美元,而去年同期为700万美元。现在转向年初至今的财务业绩。2020财年,由于常规CMP和胶版印刷纸销量下降,加上所有纸产品类别的ASP下降,总收入下降14.2%至1.009亿美元。2020财年,CMP业务板块(包括常规和轻量CMP)实现收入7920万美元,占总收入的78.4%。其中6230万美元收入来自常规CMP产品,1680万美元来自轻量CMP。CMP板块销量下降8.1%至196,885吨,其中154,084吨为常规CMP,42,801吨为轻量CMP。常规CMP的ASP下降5.2%至每吨404美元,而轻量CMP的ASP下降5.1%至每吨393美元。2020财年,我们的胶版印刷纸业务板块实现收入1230万美元。2020财年我们发运了20,358吨胶版印刷纸,较去年同期下降30.3%。胶版印刷纸的ASP下降13.9%至每吨603美元。2020财年,生活用纸产品实现收入840万美元,增加210万美元或32.5%,这源于生活用纸产品销售10,088吨,增长48.6%,ASP为每吨834美元,下降10.8%。2020财年,口罩实现收入110万美元,销售量为1030万片口罩。2020财年,总销售成本下降870万美元至9520万美元,导致总毛利润为570万美元,较去年下降58.3%。我们5.6%的总毛利率反映了较去年下降六个百分点。2020财年,销售、一般及行政费用预计为1120万美元,而去年同期为980万美元。2020财年,运营收入从390万美元下降至负550万美元。运营亏损率为5.4%,而去年同期运营利润率为3.3%。2020财年,净亏损为560万美元,基本和稀释每股亏损0.21美元,而去年同期净利润为220万美元,基本和稀释每股收益为0.10美元。2020财年,息税折旧摊销前利润从去年同期的1930万美元下降至1020万美元。转到幻灯片第25和26页,让我们看看资产负债表和流动性。截至2020年12月31日,公司拥有现金及银行存款、短期债务(包括银行贷款、信用合作社长期贷款当期部分和关联方贷款)以及长期债务(包括信用合作社贷款),分别为410万美元、1220万美元和460万美元,而2019年底分别为580万美元、830万美元和740万美元。截至2020年12月31日,净应收账款为240万美元,而2019年12月31日为310万美元。截至2020年12月31日,净库存为120万美元,而2019年底为160万美元。截至2020年12月31日,公司拥有流动资产1490万美元,流动负债1830万美元,导致营运资本赤字340万美元。相比之下,2019年底流动资产为2400万美元,流动负债为1680万美元,导致营运资本为720万美元。截至2020年12月31日止年度,经营活动产生的净现金为1610万美元,而2019年为750万美元。截至2020年12月31日止年度,投资活动使用的净现金为2050万美元,而2019年为790万美元。截至2020年12月31日止年度,融资活动产生的净现金为210万美元,而2019年融资活动使用的净现金为580万美元。
Jing Hao
Thanks and thanks everyone for being on the call. Next on behalf of the management team I will summarize some key financial results for the fourth quarter 2020. Also I will occasionally refer to specific production lines associated with various products. I will make clear which products I'm referring to. For reference the numbering system for our production lines provided on Slide number 18. Now let's look at our financial performance for the fourth quarter of 2020. Please turn to Slide number 7. For the fourth quarter of 2020, total revenue decreased 3.4% to $32.5 million due to the decrease in sales volume of CMP and offset printing paper. Turning to Slide 8. For the fourth quarter of 2020, the CMP segment including both regular CMP and light-weight CMP generated revenue of $24.9 million, representing 76.7% of total revenue. $19.7 million of revenue was from our regular CMP products and $5.2 million was from light-weight CMP. CMP segment volume slightly decreased by 3.4% to 57,627 tonnes, of which 45,210 tonnes were regular CMP and 12,417 tonnes were light-weight CMP. Average selling price or ASP for regular CMP increased by 4.3% to $435 per tonne and ASP for light-weight CMP were equal to $422 per tonne. Turning to Slide 9. For the fourth quarter of 2020, the offset printing paper generated revenue of $4.9 million, decreased by $2.3 million or 31.9% from the same period last year. The offset printing paper volume decreased by 24.4% to 7,895 tonnes. ASP for offset premium paper decreased by 9.8% to $618 per tonne. Turning to Slide 10. Tissue paper products generated revenue of $2.6 million, increased by $0.9 million or 51.3%. This resulted from sales of 3,165 tonnes tissue paper products with a 51.3% increase. An ASP of $837 per tonne with an increase of 22.4%. Turning to Slide 11. We sold 445,000 pieces of face masks and generated revenue of $1.14 million [ph] from selling face masks for the fourth quarter 2020. Slide number 12 summarizes the changes in our revenue mix. For the fourth quarter of 2020, total cost of sales increased by $3.7 million to $31.7 million leading to total gross profit of $0.7 million as compared to the gross profit of $5.6 million for the same period last year and overall gross margin of 2.3% for the fourth quarter of 2020. For the fourth quarter of 2020, SG&A expenses increased by 14.6% to $2.7 million and a loss from operations were $2 million compared to income from operations of $3.2 million for the same period last year. Operating margin was negative 6.1% compared to operating margin of 9.5% for the same period last year. For the fourth quarter of 2020, net loss was $2.7 million resulting in a net loss of $0.06 per basic and diluted share. This compared to a net income of $2.2 million or net income of $0.10 per basic and diluted share for same period last year. For the fourth quarter of 2020, earnings before interest, taxes, deprecation and amortization decreased by $5.4 million to $1.6 million from $7 million for same period last year. Now shifting gears to year-to-date financial results. For the fiscal year 2020, total revenue decreased 14.2% to $100.9 million as a result of decrease in sales volume of regular CMP offset printing paper combined with decrease in ASPs of all paper products categories. For fiscal year 2020, the CMP segment including both regular and the light-weight CMP generated revenue of $79.2 million, representing 78.4% of total revenue. $62.3 million in revenue was from our regular CMP product and $16.8 million was from light weight CMP. Volume for the CMP segment decreased by 8.1% to 196,885 tonnes, of which 154,084 tonnes were regular CMP and 42,801 tonnes were light weight CMP. ASP for regular CMP decreased by 5.2% to $404 per tonne, while ASP for light-weight CMP decreased by 5.1% to $393 per tonne. For the fiscal year 2020, our offset printing paper segment generated revenue of $12.3 million. We shipped 20,358 tonnes of offset printing paper for the fiscal year 2020, a decrease of 30.3% for the same period last year. ASP for offset printing paper decreased by 13.9% to $603 per tonne. For fiscal year 2020, tissue paper products generated revenue of $8.4 million increased by $2.1 million or 32.5%, which resulted from sales of 10,088 tonnes tissue paper product with 48.6% increase and ASP of $834 per tonne with a decrease of 10.8%. For fiscal year 2020, face masks generated revenue of $1.1 million with sales volume of 10.3 million pieces of face masks. For fiscal year 2020, total cost of sales decreased by $8.7 to $95.2 million leading to total gross profit of $5.7 million and a decrease of 58.3% from last year. Our total gross margin of 5.6% reflects a decrease of six percentage points from last year. For fiscal year 2020, SG&A expected were $11.2 million compared to $9.8 million for the same period of last year. For the fiscal year 2020, income from operations decreased from $3.9 million to negative $5.5 million. Operating loss margin was 5.4% compared to operating margin of 3.3% for the same period last year. For fiscal year 2020, net loss was $5.6 million a $0.21 loss per basic and diluted share, compared to net income of $2.2 million, earnings of $0.10 per basic and diluted each share for the same period last year. For fiscal year 2020, earnings before interest taxes depreciation and amortization decreased from $19.3 million to $10.2 million for the same period last year. Moving to slide 25 and 26, let's look at balance sheet and liquidity. As of December 31 of 2020, the company had cash and bank balances, short-term debt, including bank loans, current portion of long-term loans from credit union and related party loans and long-term debt, including loans from credit union of $4.1 million, $12.2 million and $4.6 million respectively compared to $5.8 million, $8.3 million and $7.4 million respectively at the end of in 2019. Net accounts receivable were $2.4 million as of December 31, 2020, compared to $3.1 million as of December 31, 2019. Net inventory were $1.2 million as of December 31 2020 compared to $1.6 million at the end of 2019. As of December 31, 2020, company had current assets of $14.9 million and current liabilities of $18.3 million resulting in a working capital deficit of $3.4 million. This was compared to current assets of $24 million and the current liabilities of $16.8 million, resulting in a working capital of $7.2 million at the end of 2019. Net cash provided by operating activities was $16.1 million for the year ended December 31, 2020, compared to net cash provided by operating activities of $7.5 million for 2019. Net cash used in investing activities was $20.5 million for the year ended December 31, 2020, compared to $7.9 million for 2019. Net cash provided by financing activities was $2.1 million for the year ended December 31, 2020, compared to net cash used in financing activities of $5.8 million for 2019.